Rare diseases
Investigational molecules
Locations
359 conditions with trials, the busiest first
849 trials across Europe, recruiting first
Study on Treating Scabies with Permethrin and Ivermectin for Patients with Scabies
GermanyStudy on Mesenchymal Stem Cells for Patients with Systemic Sclerosis and Digital Ulcers
The NetherlandsStudy on Valsartan for Slowing Aortic Root Dilatation in Children and Young Adults with Marfan Syndrome and Related Conditions
PolandRandomized Placebo‑Controlled Trial of Cenerimod for Efficacy and Safety in Adults with Systemic Lupus Erythematosus and Active Lupus Nephritis
BulgariaEfficacy and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Face and Neck Atopic Dermatitis
DenmarkLong-term Safety and Efficacy of ORKA-001 in Adults with Moderate-to-Severe Plaque Psoriasis (Open-Label Extension Study)
GermanyA Phase 2b Study Evaluating the Efficacy and Safety of ENV-294 in Adults with Moderate-to-Severe Atopic Dermatitis
BulgariaSafety and Efficacy Study of the Acne mRNA vaccine (mrt1800, mrt1801, mrt1802) in Adults 18‑45 Years with Moderate to Severe Acne
GermanyLong-Term Safety and Efficacy of Lebrikizumab in Children and Adolescents With Moderate-to-Severe Atopic Dermatitis
CzechiaA study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis
BulgariaTesting GIA632 compared to placebo in adults with moderate to severe atopic dermatitis to measure effectiveness and safety
BulgariaStudy of telitacicept compared to placebo in adults with moderate to severe systemic lupus erythematosus
BulgariaThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
